Adaptimmune Therapeutics PLC ADR Stock
Heavy losses for Adaptimmune Therapeutics PLC ADR today as the stock fell by -€0.070 (-6.800%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Adaptimmune Therapeutics PLC ADR stock is not clear.
On the other hand, the target price of 1 € is below the current price of 1.06 € for Adaptimmune Therapeutics PLC ADR, so the potential is actually -5.66%.
Our community identified positive and negative aspects for Adaptimmune Therapeutics PLC ADR stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Adaptimmune Therapeutics PLC ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Adaptimmune Therapeutics PLC ADR in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Adaptimmune Therapeutics PLC ADR vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Adaptimmune Therapeutics PLC ADR | -6.800% | -4.505% | -15.200% | -16.535% | 69.600% | -73.096% | - |
Tissue Regenix Group Plc | - | 0.000% | 0.000% | 8.352% | 21.239% | - | - |
Cicassia Pharmaceuticals | 6.000% | 0.000% | 10.417% | 44.545% | 13.571% | 138.024% | 147.664% |
Optibiotix Health plc | 2.910% | 3.922% | -4.505% | 92.727% | -27.891% | -61.802% | - |